Inovio Pharma Shares Spike To Recent High Following Co. Tweet 'This is the first #COVID19 vaccine clinical study approved in South Korea funded by @CEPIvaccines through INOVIO and supported by KCDC/KNIH' 9:59 am ET July 17, 2020 (Benzinga) Print
This is the first #COVID19 vaccine clinical study approved in South Korea funded by @CEPIvaccines through INOVIO and supported by KCDC/KNIH. INOVIO recently disclosed positive interim results of its Phase 1 trial in the U.S. and plans to initiate a Phase 2/3 trial this summer. pic.twitter.com/bYVZkqQ5vP
— INOVIO Pharmaceuticals (@InovioPharma) July 17, 2020
This is the first #COVID19 vaccine clinical study approved in South Korea funded by @CEPIvaccines through INOVIO and supported by KCDC/KNIH. INOVIO recently disclosed positive interim results of its Phase 1 trial in the U.S. and plans to initiate a Phase 2/3 trial this summer. pic.twitter.com/bYVZkqQ5vP
— INOVIO Pharmaceuticals (@InovioPharma) July 17, 2020